XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS (LOSS) PER SHARE (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS

The following calculates basic and diluted EPS:

 

   Three Months   Three Months 
   Ended   Ended 
   June 30, 2022   June 30, 2021 
Net income (loss), numerator, basic and diluted computation  $10,495,691   $(1,276,886)
           
Weighted average shares - denominator basic computation   1,069,157    728,966 
Effect of stock awards   2,128    - 
Effect of preferred stock   147,939    - 
Weighted average shares, as adjusted - denominator diluted computation   1,219,224    728,966 
Earnings (loss) per common share – basic  $9.82   $(1.75)
Earnings (loss) per common share – diluted   8.61    (1.75)

 

   Six Months   Six Months 
   Ended   Ended 
   June 30, 2022   June 30, 2021 
Net income (loss)  $19,835,692   $(1,890,812)
Deemed dividend   (6,930,335)   - 
Net income (loss), numerator, basic computation   12,905,357    (1,890,812)
Recognition and change in fair value of warrant liability   (26,625,915)   - 
Net income (loss), numerator, diluted computation  $(13,720,558)  $(1,890,812)
           
Weighted average shares - denominator basic computation   1,025,108    617,316 
Effect of Series B warrant liability   43,128    - 
Weighted average shares, as adjusted - denominator diluted computation   1,068,236    617,316 
Earnings (loss) per common share - basic  $12.59   $(3.06)
Earnings (loss) per common share - diluted  $(12.84)  $(3.06)
SCHEDULE OF ANTI-DILUTIVE SECURITIES IN WEIGHTED AVERAGE SHARES

Additionally, the following are considered anti-dilutive securities excluded from weighted-average shares used to calculate diluted net loss per common share:

 

           
   For the Three Months Ended 
   June 30,
2022
   June 30,
2021
 
Shares subject to outstanding common stock options   10,928    10,928 
Shares subject to outstanding Series A warrants   113,000    138,000 
Shares subject to unvested stock awards   -    3,072 
Shares subject to warrant liability   668,299    - 

 

           
   For the six months ended 
   June 30,
2022
   June 30,
2021
 
Shares subject to outstanding common stock options   10,928    10,928 
Shares subject to outstanding Series A warrants   113,000    138,000 
Shares subject to conversion of Series B preferred stock   147,939    - 
Shares subject to unvested stock awards   4,621    3,072